These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8000260)

  • 21. Pathogen inactivation technology: cleansing the blood supply.
    Klein HG
    J Intern Med; 2005 Mar; 257(3):224-37. PubMed ID: 15715679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Biologicals; 2007 Oct; 35(4):349-53. PubMed ID: 17656111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of a quality-control study of lyophilized pooled plasmas which have been 'virally inactivated' using a solvent detergent method (modified Horowitz procedure).
    Trobisch H
    Beitr Infusionsther; 1991; 28():92-109. PubMed ID: 1725667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Infections as complications of blood transfusion]].
    Kłos M
    Przegl Epidemiol; 2001; 55 Suppl 3():4-9. PubMed ID: 11984956
    [No Abstract]   [Full Text] [Related]  

  • 25. The significance of the blood-borne viruses: blood banking and transfusion medicine.
    Sherwood WC
    Dev Biol Stand; 1993; 81():25-33. PubMed ID: 8174810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C, other types of non-B parenteral hepatitis and blood transfusion.
    Dodd RY
    Dev Biol Stand; 1993; 81():35-40. PubMed ID: 8174817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bloodborne infections.
    Csete ME
    Acta Anaesthesiol Scand Suppl; 1997; 111():247-8. PubMed ID: 9421032
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current status of viral safety of virus inactivated factor VIII and IX concentrates in treatment of hemophilia].
    Pollmann H
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():80-3. PubMed ID: 8000261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusional transmitted viruses in pregnancy.
    Eleftheriou A; Kalakoutis G; Pavlides N
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():901-14. PubMed ID: 10091164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia.
    Mariani G; Di Paolantonio T; Baklaya R; Morfini M; Mannucci PM
    Transfusion; 1993 Oct; 33(10):814-8. PubMed ID: 8236421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks associated with fresh whole blood and red blood cell transfusions in a combat support hospital.
    Spinella PC; Perkins JG; Grathwohl KW; Repine T; Beekley AC; Sebesta J; Jenkins D; Azarow K; Holcomb JB;
    Crit Care Med; 2007 Nov; 35(11):2576-81. PubMed ID: 17828033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of genetic diagnosis in clinics--from the choice of ordering until reading the data].
    Nakamura Y
    Rinsho Byori; 1999 Nov; 47(11):1006-13. PubMed ID: 10590677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates.
    Goldsmith JC
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):203-15. PubMed ID: 10759015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfusion-transmitted viral infections other than hepatitis and human immunodeficiency virus infection. Cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, and human parvovirus B19.
    Sayers MH
    Arch Pathol Lab Med; 1994 Apr; 118(4):346-9. PubMed ID: 8166584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply.
    AuBuchon JP; Birkmeyer JD
    JAMA; 1994 Oct; 272(15):1210-4. PubMed ID: 7933351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfusion-transmitted viruses.
    Wright-Kanuth MS; Smith LA
    Clin Lab Sci; 2003; 16(4):221-9. PubMed ID: 14626440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.